United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 6, 2026 · Filed Aug 7, 2026

On Aug 6, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$525.36 for US$4.99M under a trading plan, leaving 324,443 shares. Filed Aug 7, 2026 (Form 4).

Sold
9,500 shares
Price
US$525.36 average (US$512.50 to US$532.39)
Value
US$4.99M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 6, 2026Common StockSale80US$512.50333,863Indirect
Aug 6, 2026Common StockSale625US$514.92333,238Indirect
Aug 6, 2026Common StockSale263US$516.21332,975Indirect
Aug 6, 2026Common StockSale120US$516.73332,855Indirect
Aug 6, 2026Common StockSale80US$517.83332,775Indirect
Aug 6, 2026Common StockSale80US$519.18332,695Indirect
Aug 6, 2026Common StockSale633US$520.79332,062Indirect
Aug 6, 2026Common StockSale719US$521.63331,343Indirect
Aug 6, 2026Common StockSale120US$522.86331,223Indirect
Aug 6, 2026Common StockSale182US$524.24331,041Indirect
Aug 6, 2026Common StockSale824US$525.42330,217Indirect
Aug 6, 2026Common StockSale1,357US$526.32328,860Indirect
Aug 6, 2026Common StockSale1,283US$527.22327,577Indirect
Aug 6, 2026Common StockSale875US$528.28326,702Indirect
Aug 6, 2026Common StockSale759US$529.33325,943Indirect
Aug 6, 2026Common StockSale680US$530.42325,263Indirect
Aug 6, 2026Common StockSale400US$531.42324,863Indirect
Aug 6, 2026Common StockSale420US$532.39324,443Indirect

Source

View original at SEC

Related